Jefferies analyst Raj Denhoy raised the price target on DexCom (NASDAQ: DXCM) to $655.00 (from $610.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

DexCom (DXCM) PT Raised to $660 at UBSOctober 29, 2021 7:36 AM DexCom (DXCM) PT Raised to $675 at Piper SandlerOctober 29, 2021 7:31 AM UPDATE: DexCom (DXCM) PT Raised to $625 at Canaccord Genuity (CORRECTION)October 29, 2021 5:57 AM Form 10-Q DEXCOM INC For: Sep 30October 28, 2021 5:16 PM Form 8-K DEXCOM INC For: Oct 28October 28, 2021 4:07 PM DexCom (DXCM) Tops Q3 EPS by 26cOctober 28, 2021 4:03 PM Dexcom Reports Third Quarter 2021 Financial ResultsOctober 28, 2021 4:02 PM